Myriad Genetics Inc (NAS:MYGN)
$ 26.835 0.445 (1.69%) Market Cap: 2.44 Bil Enterprise Value: 2.44 Bil PE Ratio: 0 PB Ratio: 3.29 GF Score: 78/100

Q4 2019 Myriad Genetics Inc Earnings Call Transcript

Aug 13, 2019 / 08:30PM GMT
Release Date Price: $44.55 (-1.61%)
Operator

Greetings and welcome to the Myriad Genetics Fourth Quarter 2019 Financial Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded Tuesday, August 13, 2019. I would now like to turn the conference over to Scott Gleason, VP, Investor Relations. Please

(technical difficulty)

Scott Gleason
Myriad Genetics, Inc. - VP of IR

Thanks, Kevin. Good afternoon, and welcome to the Myriad Genetics Fiscal Fourth Quarter 2019 Earnings Call. My name is Scott Gleason, and I'm the Head of Investor Relations and Corporate Strategy at Myriad. During the call, we will review the financial results we released today, after which we'll host a question-and-answer session. If you've not had a chance to review the earnings release, it can be found in the Investor Relations section of our website at myriad.com. Presenting for Myriad today will be Mark Capone, President and Chief Executive Officer; and Bryan Riggsbee, Chief Financial Officer. This call can be heard live via webcast at myriad.com. The call is being recorded and will be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot